📊 Score Breakdown
Offering Ability
40
Cash Runway
65
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
35%
🔄 Reverse Split
40%
• 50-day avg $1.19 approaching $1 threshold
• 7 months cash with weak price
📉 Score Deterioration
40%
• Score rose 25 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (7mo)
💹 Market Data
Market Cap$22.49M
Shares Outstanding19.56M
Float15.71M
Cash$18.16M
Debt$293.0K
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 14.18M shares
#1
Nantahala Capital Management, LLC
2.67M shares
#2
Adage Capital Partners GP L.L.C.
2.25M shares
#3
Vanguard Group Inc
2.08M shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest1.76M
Days to Cover2.3
% of Float11.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2019
4
INSIDER TRANSACTION
Jan 23, 2026
4
INSIDER TRANSACTION
Jan 23, 2026
4
INSIDER TRANSACTION
Jan 23, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for QNCX
📊 QNCX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 QNCX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.